Tweenvest Stocks

Shanghai Yizhong Pharmaceutical Co., Ltd. (SHSE: 688091)

Health Care · Pharmaceuticals · CN

CN¥36.80

-6.60% today · -35.0% 1Y

Shanghai Yizhong Pharmaceutical Co., Ltd. (SHSE: 688091) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.13B and employs 437 people.

Over the last twelve months the share price has lost 35.0%, trading between 35.28 and 66.20.

Tweenvest scores Shanghai Yizhong Pharmaceutical Co., Ltd. across four factors: quality 67/100, value 48/100. Its strongest factor is quality.

688091 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$1.13B
Revenue (TTM)
$47.35M
P/E
107.92
EPS
0.34
Dividend yield
—
Beta (5Y)
-0.44
52-week high
CN¥66.20
52-week low
CN¥35.28
Avg volume (3M)
—
Shares outstanding
204.80M
Employees
437
Next earnings
—

About Shanghai Yizhong Pharmaceutical Co., Ltd.

Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the development of anti-tumor drugs and related products in China. It also offers paclitaxel polymer nanomicelles for the treatment of non-small cell lung cancer, as well as various types of cancer, including esophageal cancer, gastric cancer, nasopharyngeal carcinoma, pancreatic cancer, breast cancer, gynecological tumors, etc. The company was founded in 2009 and is headquartered in Shanghai, China.

ISIN
CNE1000050F4
Founded
2009
Listed since
Sep 9, 2021
Exchange
Shanghai Stock Exchange
Currency
CNY
CompanyMarket capPriceDay
Jiangsu Yahong Meditech Co., Ltd.SHSE: 688176$1.14BCN¥13.47-7.74%
Amphastar Pharmaceuticals, Inc.NasdaqGS: AMPH$1.13B$26.62+3.14%
Jiuzhitang Co., Ltd.SZSE: 000989$1.13BCN¥8.91+1.83%
Towa Pharmaceutical Co., Ltd.TSE: 4553$1.13B¥3,620.00+3.58%
Sichuan Huiyu Pharmaceutical Co., Ltd.SHSE: 688553$1.10BCN¥11.85-7.78%
Harrow, Inc.NasdaqGM: HROW$1.10B$29.36-3.80%
Renhe Pharmacy Co.,LtdSZSE: 000650$1.09BCN¥5.29+0.95%
Guilin Sanjin Pharmaceutical Co., Ltd.SZSE: 002275$1.08BCN¥12.35+1.06%

Browse every Pharmaceuticals company →

Figures last refreshed Oct 11, 2026.